Announcements Trials
Browse Landscape

Status

Completed 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Smoking Cessation 1Smoking 1Sinonasal undifferentiated carcinoma 1Radiation Injuries 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1NSCLC 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 29Carboplatin 27Specimen Handling 21durvalumab 20Pemetrexed 18Cisplatin 17Paclitaxel 16atezolizumab 15Nivolumab 15Magnetic Resonance Spectroscopy 15osimertinib 11Radiosurgery 11Radiotherapy 10Immunoglobulin G 10Etoposide 10Docetaxel 10Disulfides 10Radiation 9Taxes 8Gemcitabine 8Biopsy 8Blood Specimen Collection 7Standard of Care 6Practice Guidelines as Topic 6Ipilimumab 6Surveys and Questionnaires 5Platinum 5Bronchoscopy 5Bevacizumab 5Ramucirumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lung Neoplasms × Chemoradiotherapy × Clear all
NCT04305613 2025-10-02

CLARITY

Abramson Cancer Center at Penn Medicine

Active not recruiting
221 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Radiation Injuries, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡